Carolina Dybeck Happe
Analyst · America, we have Andrew Obin. Please go ahead
Thanks, Larry. Our quarterly performance reflects continued progress in our transformation. During a recent operating review, we're gaining traction with increased granularity across our financials. Our [financials] (ph) are providing more insightful, faster analysis, which is driving better outcomes. Looking forward, we're focused on building even deeper visibility and accountability, partnering cross-functionally, to unlock margin expansion and improving working capital management to generate more cash flow. Now, looking at Slide 4. I'll cover our highlights on an organic basis. In the quarter, we returned to growth on the topline. Healthcare and Services overall were strong. In particular, Services continued to keep us close to our customers and represent more than half of our orders and revenue. Total orders were up 7% sequentially, and Aviation and Power were up more than 40% year-over-year. Services orders were up 50%, where Renewables and Aviation doubled, and Gas Power and Healthcare grew double-digits. Revenue was up across Aviation, Healthcare, and Renewables. Power was flat as expected. We continued to reduce turnkey scope in Gas Power and exit new unit coal at Steam. We're also seeing our mix shift towards higher margin services, with total services revenue growing 15%. Notably, Aviation Commercial Services grew 50%, reflecting a recovering market, but we're still well below '19 levels. Healthcare in total, and Gas Power Services remain bright spots with growth above 2019. Next, adjusted Industrial margins improved sequentially in all segments except Aviation, where margins declined. I'll speak to this shortly. Year-over-year, margins expanded 1,000 basis points, with all segments expanding. About half of this improvement was driven by non-repeat of COVID charges, and the other half was driven by our Lean efforts, cost productivity, and mix shift to Services. Regarding inflation, we're seeing pressure. However, it's a mixed story by business. Our shorter cycle businesses feel the impact earliest, while our longer cycle businesses are more protected, given extended purchasing and production cycles. Our services business fall in between. Across the board, we're driving cost countermeasures and utilizing price increases and escalation features in our contracts to help mitigate this pressure. In our longer-cycle project businesses, we manage cost performance versus our original as-sold margins. We utilized Lean to reduce cost and cycle time to execute delivery. In the second quarter, our countermeasures actually drove a slight net deflation impact on margins. Looking forward to the second half of '21 and into '22, although inflation pressure is likely to increase, particularly in Aviation and Renewables, we expect the net inflation impact to be limited. Finally, Adjusted EPS was up $0.19 year-over-year. About 3/4 of this improvement came from our industrial segments. As we worked from continuing to Adjusted EPS, we need to exclude the positive Baker mark, the negative impact of significant higher cost-restructuring programs, non-operating expenses primarily pension, and debt tender costs. Worth noting for EPS, our reverse stock split takes effect as of market open 08/02. This will better align GE's number of shares outstanding with companies of our size. Overall, we're encouraged by our broader earnings performance, especially the underlying margin improvement. And we're well-positioned to achieve our '21 outlook for margin expansion and EPS. Moving to cash. In the second quarter, industrial free cash flow was positive 388 million, up 2.5 billion year-over-year on a reported basis, or up 2 billion excluding discontinued factoring programs in both years. The majority of this improvement was driven by cash earnings, with all segments growing earnings. Underpinning our solid quarterly performance versus our earlier expectations, was higher Aviation orders, and in turn, higher progress collections and lower AD&A, as well as strength at Healthcare and Power. We've made good progress exiting the majority of our factoring programs in the second quarter. This was a big step forward to becoming more operational and getting back to basics on billings and collections. For context, currently, about half of our billings occur in the final month of the quarter, driven in part by the timing of deliveries, far too backend-loaded and inconsistent with the Lean principles of flow and level loading. Our turns across commercial, operations and finance are working to deliver earlier to our customers. And in turn, bill and collect cash earlier in the quarter. Over time this will help us generate more linear cash flow. The discontinuation of factoring was a 2.7 billion impact, which was adjusted out of free cash flow. For the remainder of 21, the impact will be roughly a billion dollars part, stick between the third and the fourth quarters. Going deeper on working capital, this was a source of cash at 260 million this quarter. Despite increased volume, we saw significant year-over-year improvement, largely due to operational enhancements. Looking at the flows in the quarter, I'll speak to a couple. Receivables were a source of cash, driven by DSO improvement across all segments. Take our Imaging and Life Care Solution business in the U.S. and Canada, for example. Our turns are using Lean and automation to better manage contract deliverables, build customers more accurately and faster, and thereby generate cash quicker. These efforts already improved DSO by 7 days. Inventory with the use of cash largely driven by Onshore Wind inventory build for the second -half delivery as well as fulfillment and execution challenges. Overall, inventory turns improved from 2.4 to 2.6 sequentially with higher volume, but there's much more to do. We continue to manage our capital investments with focus on profitable growth. When the second quarter CapEx spend was down sequentially, our investments in new product programs increased. Overall, in the first half, on a reported basis, cash flow was negative 457 million, a 3.8 billion improvement year-over-year. Off the rebaselining for discontinued factoring programs and the BioPharma side, we saw a 3.2 billion improvement. While there is more to do, our near-term working capital improvements are taking hold even as we grow. Together with higher earnings, this is beginning to drive more sustainable and linear free cash flow. And based on our 2Q performance, we're now confident that we can deliver free cash flow in the range of 3.5 to 5 billion for the year, versus our prior outlook of 2.5 to 4.5. Turning to liquidity and leverage on Slide 6. We ended the quarter with 22 billion of cash and recently refinanced our backup credit facility. Due to our improved financial position and cash linearity with lower peak quarterly net, we reduced the facility size from 15 to 10 billion and extended the maturity date to 2026, at attractive pricing. We also continued to take meaningful actions on our deleveraging plan, completing a 7 billion debt tender. This brings our gross debt, which currently includes pension to a reduction of 53 billion since the end of 2018. Additionally, we continue to de-risk the pension. In the UK, as of January 2022, we implement the proposed pension phase. As mentioned previously, we don't expect any further funding requirements for the GE Pension Plan, at least through the end of the decade. Stepping back, we have a clear path to achieving a less than 2.5 times net debt to EBITDA over the next few years. Moving to our business results which I'll speak to on an organic basis. First, on Aviation. As Larry shared, we're starting to see improving fundamentals associated with the commercial market recovery across services and OE production. The market's sequential improvement met our expectations with GE CFM departures currently down about 27% versus '19. While departure trends continue to vary by region, we still expect the global recovery to accelarate in the second half. Orders were up year-over-year, both Commercial Engines and Services were up substantially year-over-year. Key commercial wins this quarter include IndiGo, Southwest, and United, driving momentum. In fact, since the beginning of '20 new wins have now outpaced canceled orders. Military orders were down largely due to timing of new orders and a tough comp versus last year when you will recall, we received a large military advance. Revenue was up 10%. Commercial Services was up 50% with operational improvement. Shop visit volume trended better than our expectations, up over 30%, and overall scope was up slightly, sequentially. Broadly, we're seeing higher concentration of narrow-body visits, which typically have lower revenue. Our spare part rate was up double-digits year-over-year and sequentially. This was partially offset by unfavorable CSA contract margin reviews or CMRs, where revenue is adjusted to reflect latest margins based on cost incurred to date. Military continues to be impacted by internal and external supply chain issues, with output expectations falling short this quarter. We're seeing some improvement as we used visual management and standard work and also other tools to solve problems in real-time, and we are working to fully resolve these issues. We're now targeting mid single-digit revenue growth for the year. But our high single-digit target remains in place through '25. Segment margin expanded significantly year-over-year, yet down sequentially. Margin was impacted by the non-cash contract margin review charges of, approximately, 400 million. About two-thirds of this was related to 1 contract in a loss position. In this contract, continued COVID re-utilization, contract-specific dynamics, and operating behavior increased our estimated shop visit costs. When rare across our service portfolio, the loss contract designation resulted in the accelerated recognition of all future forecasted losses into 2Q. Excluding this, Aviation margins would have been low double-digits. Quarterly CMRs are part of our normal process and we'll continue in the second half. For Q2 -- for Q3, we expect margins to expand sequentially. Our team continues to align fixed cost and our organizational profile to market realities. We're maintaining our low double-digit margin guide for '21 supported by second half recovery. However, based on the CMR and military dynamics, we now expect full-year revenue growth to be about flat versus '20. These are temporary issues and we remain encouraged by the underlying fundamentals of our business. Moving to Healthcare, market fundamentals are improving and the team delivered another impressive quarter. Starting with the market, global procedures volume grew mid single-digits for the fourth consecutive quarter. Europe, China, and Japan were solid markets due to government spending, a sign of increasing expectations for better quality of care and patient outcomes. Private markets also grew in the U.S. across key customers as recovery momentum continues. Demand remains robust amid that backdrop. Orders were up double-digits year-over-year and versus second quarter, '19, and up 20%, excluding the Ford ventilator partnership last year. Healthcare system orders were up 7% with double-digit growth in Imaging and Ultrasound. This offsets a decline in Life Care Solutions, lapping higher demand for COVID-19 -related equipment. However, LCS was up double-digits versus second quarter '19. PDx orders were up almost 50% year-over-year following a depressed second quarter '20, and also up versus second quarter '19. Revenue was also up double-digits with the HCF up 6%, and PDx up almost 50%. All Asia regions delivered double digit growth, with China up high-teens. The teams worked across the supply chain to help mitigate industry-wide supply shortages related to electronics and resins, which impacted growth this quarter. Segment margin expanded 460 Basis points year-over-year and significantly versus second quarter 19, ex-BioPharma. Margin continues to be driven by profitable growth, cost productivity throuh Lean, and prior periods restructuring. At the same time, we're accelerating our growth investments, particularly in digital and AI enabled applications with increased spend planned for the second half. And we'll continue to evaluate inorganic investments to compliment this, such as Zionexa. Based on our first-half we now expect organic margins to expand more than a 100 basis points for the year. This will be influenced by how quickly we can ramp certain growth investments. However, our medium term expectations remain 25-75 basis points expansion. Our investment ramp will support continued innovation and help us drive higher revenue growth over time. Turning to Renewables. We're continuing to lead the energy transition, growing new-generation, lowering the cost of electricity, and modernizing the grid. With a focus on new product platforms and technologies that enables profitable growth and cash generation over time. Looking at the market, in Onshore Wind, we still expect the U.S. market to decline in the near term before stabilizing. We're watching the potential U.S. production tax credit extension closely. A blanket long-term extension likely result in near-term uncertainty because it pushes out investment -- Investment decisions for what could be years. This may impact our second half orders profile and positive free cash flow outlook for the year. In Offshore Wind, global momentum should continue through the decade. The recent U.S. Federal approval of the Vineyard Wind Project, supported by our Haliade-X, represents meaningful progress for the U.S. market. And as the global energy transition accelerates and government stimulus increases, the grid will need to be upgraded and more actively managed. Orders grew mid-single-digits, where Onshore Services more than doubled as repower orders increased, which will convert to second half deliveries. This was partially offset by lower Onshore Equipment orders due to PTC dynamics. While both Onshore and Offshore Equipment orders are lumpy, we expect them to increase significantly in the second half versus first half. Revenue was up 9% driven by higher equipment revenue, offset by lower services, and reported equipment was up 12% on a two-year view versus '19. In Onshore, equipment was up year-over-year on higher international unit deliveries, while services were down on fewer repower upgrades, so up sequentially. And Services ECS repower grew double-digits again. Segment margin, while still negative, improved more than 500 basis points as we drive towards segment profitability over time. Onshore was profitable in the quarter and year-to-date. This was driven by continued cost-out and volume leverage that more than offset mix and other headwinds such as lower margin on new products, which typically improves our product lifecycle. In Grid, cost productivity was offset by elevated restructuring. Looking ahead, we're focused on our operational priorities, including cost reductions, to help offset increased medium-term headwinds from the market inflation and new technology and platform transitions. Moving to Power. The team performed very well with operational improvements across the business, particularly at Gas Power. Looking at the market, global gas generation grew low single-digits, while GE gas turbine utilization continued to be resilient, with megawatt hours growing high single-digits. Encouragingly, outage starts were up 50% year-over-year and up mid-single-digits versus 2Q '19. For the year, we expect the gas market to remain stable, with gas generation growing low-single-digits. The dispatch of our fleet is well-positioned with upgrade admissions and the growing hedging backlog. Outside of gas, markets remain mixed. Power orders were up significantly, driven by gas power equipment. This quarter, we booked 12 heavy-duty gas turbines and 35 aeroderivative orders, primarily LMs, that will complement variable renewable power by providing distributed [Inaudible] power to help deliver grid stability. Orders were also up in Gas Power Services, Lean, Power Conversion and Nuclear. Power revenue was flat, where Gas Power declined, while Power Conversion grew. Gas Power was down slightly, largely driven by equipment where, similar to last quarter, we had lower turn to scope projects. We also shipped 6 fewer heavy-duty gas turbines. Gas Power Services was up significantly across both services and transaction portfolios, primarily due to higher outages, and Services' growth is trending better than our initial outlook. Power conversion was up with its highest quarterly sales level since third quarter '18. And where Steam was down slightly, Services returned to pre-COVID level. Total power margins expanded roughly 900 basis points and improved sequentially. Gas Power has stabilized through rightsizing the cost structure, improving underwriting, and operating better with Lean. Margins were positive, largely driven by service d equipment mix and lower costs. Now, Q3 is typically our toughest service quarter, with lower activity compared to the Spring and the Fall outages season, which are in the second and the fourth quarter respectively. But we're confident in our high single-digit margin outlook for the year. Steam was negatively impacted by COVID in India, which drove work stoppages and delayed project execution. But we're on track with the planned exit of new build coal. Just over half of the planned 600 to 700 million cash actions from restructuring, legal, and project close-outs were realized in the first half. Once the exit is completed, Steam will be 2/3 services. Overall, Power is on track to deliver the outlook targets and high single-digit operating margins over time. Moving to GE Capital on Slide 8. Continuing adjusted earnings were positive 28 million, a significant improvement year-over-year. This was primarily driven by lower marks in impairments, as well as higher gains at EFS, better performance at Insurance, and the discontinuation of preferred dividend payments, which are now a GE industrial obligation. At Insurance, we saw positive investment results and lower claims continue. However, favorable claims trends due to COVID are slowing in certain parts of the portfolio. And EFS enabled 1.1 billion of orders supporting customers at Renewables and Gas, including third-party financing. Based on our first half, we expect to reach the better end of our earnings outlook of negative 700 to negative 500 million. Within discontinued operations, capital reported a loss of approximately 600 million, primarily due to the recent declines of AerCap stock price, which is updated quarterly. Moving to Corporate. Costs are up slightly, given the variable nature of [Indiscernable] and other, and the elimination activities. Importantly, functional costs and operations were better. In the first half, total costs were down more than 20%, as we improved functions and operations, and digital operations. Moving forward, our focus on decentralization and leaner processes continues, which will drive cost and cash improvement. For the year, we're on track for the 1.2 to 1.3 billion of cost. In all, we delivered a strong quarter. I'm encouraged by the work underway at Aviation, the ongoing strength in Healthcare, and our progress at Renewables and Power. Now, Larry, back to you.